Proto Labs, Inc.
PRLB
$37.61
-$1.11-2.87%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 499.21M | 500.89M | 504.19M | 509.27M | 505.91M |
| Total Other Revenue | -- | 160.00K | 416.00K | 604.00K | 809.00K |
| Total Revenue | 499.21M | 500.89M | 504.19M | 509.27M | 505.91M |
| Cost of Revenue | 277.77M | 277.69M | 277.13M | 280.17M | 280.22M |
| Gross Profit | 221.43M | 223.20M | 227.06M | 229.11M | 225.68M |
| SG&A Expenses | 157.53M | 156.41M | 156.14M | 156.00M | 153.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 476.04M | 475.39M | 474.36M | 477.59M | 474.51M |
| Operating Income | 23.16M | 25.50M | 29.83M | 31.69M | 31.39M |
| Income Before Tax | 22.93M | 24.67M | 34.89M | 35.76M | 30.64M |
| Income Tax Expenses | 8.01M | 8.08M | 10.91M | 11.01M | 10.81M |
| Earnings from Continuing Operations | 14.92 | 16.59 | 23.99 | 24.75 | 19.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.92M | 16.59M | 23.99M | 24.75M | 19.83M |
| EBIT | 23.16M | 25.50M | 29.83M | 31.69M | 31.39M |
| EBITDA | 58.89M | 61.63M | 66.86M | 69.14M | 69.37M |
| EPS Basic | 0.60 | 0.66 | 0.94 | 0.96 | 0.77 |
| Normalized Basic EPS | 0.72 | 0.75 | 0.95 | 0.96 | 0.84 |
| EPS Diluted | 0.60 | 0.65 | 0.94 | 0.96 | 0.76 |
| Normalized Diluted EPS | 0.72 | 0.75 | 0.95 | 0.96 | 0.84 |
| Average Basic Shares Outstanding | 98.90M | 100.39M | 101.74M | 102.78M | 103.68M |
| Average Diluted Shares Outstanding | 99.31M | 100.65M | 102.07M | 103.08M | 103.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |